FormWeb • bivalirudin

IHS FormWeb

Approved Formulary

Staff Telephone Numbers

Webpage Links

Add Formweb to your mobile device

Android iOS

Search results for:

bivalirudin

bivalirudin

Restricted Medications Cardiac Monitor (IV)

Brand names: Angiomax

Form	Strength
POWDER FOR INJECTION, INTRAVENOUS	250 mg

Display Direct Thrombin Inhibitors Class: 20120412

High Alert Drug : Policy

Medication comments:

High Alert Drug: direct thrombin inhibitors
• Nurses and pharmacists verify dose and that patient is not on heparin or other anticoagulant prior to administration. • Two RNs independently verify dose prior to administration if the dosing requires manipulation (i.e. drawing up a portion of a vial, or giving a portion of a syringe}. • Anticoagulation comparison chart available on nursing units for reference. • Pharmacists/nurses provide patient education for oral anticoagulants. • Pharmacists monitor labs for appropriate dosing and prevention of adverse events. • Reversal agents and order sets for oral anticoagulants

High Alert Drug: direct thrombin inhibitors

• Nurses and pharmacists verify dose and that patient is not on heparin or other anticoagulant prior to administration.
• Two RNs independently verify dose prior to administration if the dosing requires manipulation (i.e. drawing up a portion of a vial, or giving a portion of a syringe}.
• Anticoagulation comparison chart available on nursing units for reference.
• Pharmacists/nurses provide patient education for oral anticoagulants.
• Pharmacists monitor labs for appropriate dosing and prevention of adverse events.
• Reversal agents and order sets for oral anticoagulants

Per policy, these medications require cardiac and/or special monitoring. (KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
generic (Brand) / Notes
bivalirudin (Angiomax) IV	Y	Y	N	N	N	N	N	N

Anticoagulant / Antiplatelet Stoppage For Procedures
generic (Brand)	Dept.	Procedure Type (hover over entry for examples)	Stop Medication Prior To Procedure Restart after:
bivalirudin (Angiomax)	Anesthesia	High-risk	No data Restart after No data
		Intermediate-risk	No data Restart after No data
		Low-risk	No data Restart after No data
		Patients with high risk of bleeding (eg, old age, history of bleeding tendency, concurrent uses of other anticoagulants/antiplatelets, liver cirrhosis or advanced liver disease, and advanced renal disease) undergoing low- or intermediate-risk procedures should be treated as intermediate or high risk, respectively.

	Radiology	Invasive Procedures	8 hours
	Radiology	Paracentesis/Thoracentesis	No hold
	Surgery	High-risk	No data Restart after No data
	Surgery	Low-risk	No data Restart after No data

Last updated: Jun. 12, 2024

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556

This site is intended for the staff of Iredell Memorial Hospital.
While others may view accessible pages, Iredell Memorial Hospital makes no warranty, express or implied,
as to the use of this information outside of Iredell Memorial Hospital.
The content of this policy and procedure document serves as guidance to the delivery of quality patient care.
Care providers are expected to exercise critical thinking and situational awareness skills,
and in specific situations to take such action as is necessary for the delivery of quality patient care.